Literature DB >> 33705498

Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.

Friederike Lämmer, Claire Delbridge, Silvia Würstle, Frauke Neff, Bernhard Meyer, Jürgen Schlegel, Kerstin A Kessel, Thomas E Schmid, Daniela Schilling, Stephanie E Combs.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0221502.].

Entities:  

Year:  2021        PMID: 33705498      PMCID: PMC7951894          DOI: 10.1371/journal.pone.0248612

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  1 in total

1.  Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.

Authors:  Friederike Lämmer; Claire Delbridge; Silvia Würstle; Frauke Neff; Bernhard Meyer; Jürgen Schlegel; Kerstin A Kessel; Thomas E Schmid; Daniela Schilling; Stephanie E Combs
Journal:  PLoS One       Date:  2019-08-20       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.